SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-104739
Filing Date
2024-09-09
Accepted
2024-09-09 16:05:10
Documents
21
Period of Report
2024-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20240909.htm   iXBRL 8-K 58801
2 EX-99.1 ktra-ex99_1.htm EX-99.1 34457
3 EX-99.2 ktra-ex99_2.htm EX-99.2 29990
4 EX-99.3 ktra-ex99_3.htm EX-99.3 21903
5 GRAPHIC img40499469_0.jpg GRAPHIC 19478
6 GRAPHIC img41422990_0.jpg GRAPHIC 1560
7 GRAPHIC img41422990_1.jpg GRAPHIC 50940
8 GRAPHIC img41422990_2.jpg GRAPHIC 36444
9 GRAPHIC img41422990_3.jpg GRAPHIC 47224
10 GRAPHIC img41422990_4.jpg GRAPHIC 34221
11 GRAPHIC img42346511_0.jpg GRAPHIC 33703
  Complete submission text file 0000950170-24-104739.txt   601657

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20240909.xsd EX-101.SCH 27216
23 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20240909_htm.xml XML 4909
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 241287262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)